Impact Factor
3.08
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.87
382 total citations
h5-index
26
h5 depth signal
Cited share
50.6%
79 of 156
Total citations
382
Citation footprint
Metric signal
2.36
External metric anchor
Self-citation
23.0%
88 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Germany
272
United States
252
United Kingdom
130
Netherlands
129
Italy
129
Citing Fields of Research
Pharmacology & Toxicology
477
Molecular & Cellular Toxicology
141
Allergies
91
Stem Cell Biology
83
Medical Ethics
64
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,240
Articles tracked across the journal lifetime
Indexed publication set
156
79 cited publications
Last 12 months
65
32.5 publications/month
Open access share
55.4%
36 OA publications in the last year
Leading citing country
Germany
272 citing publications
Leading citing field
Pharmacology & Toxicology
477 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v17n1, 2000-
v17n1, 2000-
Active Coverage
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Issuing & Sponsoring Bodies
Contributor
Mitteleuropäische Gesellschaft für Alternativmethoden zu Tierversuchen
Contributor
Johns Hopkins Center for Alternatives to Animal Testing
Contributor
European Society for Alternatives to Animal Testing
Contributor
Society ALTEX Edition
Broad Categories
Laboratory Animal Science
Pharmacology & Toxicology
Agrochemicals & Ground Poisoning
Allergies
Medical Ethics
MeSH Descriptors
Animal Testing Alternatives
Animal Welfare
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.14573/altex.2606081
Open DOI
Borrow, don't breed: How historical controls can cut concurrent animal numbers
Recommendation 013/2026 of the German Federal Institute for Risk Assessment (BfR) considers a reduction of concurrent control animals possible when historical control data demonstrate stability. However, the recommendation provides no me...
02
DOI 10.14573/altex.2608271
Open DOI
A roadmap for modernizing vaccine safety assessment: Challenges and opportunities for new approach methodologies
Vaccines are administered to large populations of healthy individuals, including vulnerable groups, making an exceptionally rigorous safety profile a prerequisite for their approval and use. Nonclinical vaccine safety assessment has trad...
03
DOI 10.14573/altex.2608091
Open DOI
Validation by design: Model-informed validation design (MIVD) as a quantitative design science
Validation underpins confidence in test methods and integrated testing strategies, yet while the methods under evaluation have been transformed, the design of validation studies remains governed by convention and feasibility rather than...
04
DOI 10.14573/altex.2607161
Open DOI
R3FINE 2026: Bridging disciplinary gaps in translational animal-free research
05
DOI 10.14573/altex.2605181
Open DOI
Linking nuclear receptor antagonism with neuronal morphology improves detection of developmental neurotoxicants
Brain development is highly dependent on hormonal signaling, hence developmental exposure to endocrine disrupting chemicals (EDCs) is of high concern. However, existing EDC hazard assessment methods lack the capacity to connect developme...
06
DOI 10.14573/altex.2606132
Open DOI
HepaRGTM CYP induction test method augmentation part 2: Study supported by mRNA analysis
Cytochrome P450 (CYP)-mediated biotransformation of endogenous and xenobiotic substances can lead to altered exposure, toxicological impact, or adverse drug reactions. CYP induction data are fundamental to regulatory chemical hazard asse...
07
DOI 10.14573/altex.2606131
Open DOI
HepaRGTM CYP induction test method augmentation part 1: The GOLIATH Study
Cytochrome P450 (CYP) enzymes play a key role in the metabolism of both xenobiotics and endogenous com-pounds, and some CYP isoforms are susceptible to induction and/or inhibition by certain chemicals. As CYP induction/inhibition can sig...
08
DOI 10.14573/altex.2608201
Open DOI
ECHA writes back: The reasons for rejection of read-across in compliance check decisions by the European Chemicals Agency
Read-across is the most widely used adaptation to standard information requirements under REACH and is central to efforts to reduce unnecessary animal testing. However, its regulatory acceptance in European Chemicals Agency (ECHA) compli...
09
DOI 10.14573/altex.2606062
Open DOI
Beyond the drug-centric view: Advancing AI virtual cell platforms for environmental perturbation modelling
Environmental exposures contribute substantially to global morbidity and mortality, with their biological effects shaped by factors such as dose, exposure duration, life-stage timing, and cumulative or sequential exposure patterns. With ...
10
DOI 10.14573/altex.2607011
Open DOI
Educational and training needs of regulatory professionals for non-animal methodologies: Insights from a survey
The increasing application of non-animal new approach methodologies (NAMs) in regulatory decision-making requires regulatory professionals to develop new competencies to confidently interpret data derived from this expanding array of met...
Bibliographical & Catalog Notes
Issues for Vol. 22, no. 2 (2005)- have subtitle: Alternatives to animal experimentation.
Issues for 1994- Vol. 22, no. 1 (2005) have subtitle: Alternativen zu Tierexperimenten.
Print issues ceased with 2016.
Also issued online.
German and English; in English, <2009-> .
Official organ of: Mitteleuropäischen Gesellschaft für Alternativmethoden zu Tierversuchen; CAAT,<2009->; EUSAAT <2009->. From 2017- , official organ of: ASCCT, CAAT, CAAT-Europe, Doerenkamp chairs, ecopa, EUSAAT, t4.
v.11, no. 1 (1994)20001213 Notice published Printed on acid-free paper